OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 08, 2016
WellSpring Pharma formed a strategic partnership with IDT Australia and invested $3 million in new equipment.
April 02, 2016
A program for calibration and routine testing of weighing instruments ensures accurate results.
Transferring the manufacturing of a drug from one scale to another or between manufacturing sites presents both technical and business challenges.
Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems.
Demand is driving expansion and consolidation of formulation and clinical trial materials services.
April 01, 2016
At DCAT's annual meeting, Bill Downey, president of the market research firm High Tech Business Decisions, summarized results from its latest survey on biopharmaceutical outsourcing.
March 24, 2016
Collaboration will provide for unified development and manufacture of antibody drug conjugates.
March 10, 2016
Hovione will operate a commercial-scale continuous manufacturing facility in New Jersey as part of an agreement with Vertex Pharmaceuticals.
March 02, 2016
Global economic and political uncertainty could slow bio/pharma development activity.
The pharma outsourcing market starts 2016 with expansions, acquisitions, and new offerings.